Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements

Download results of this page

Refine by:




Australia (1)
Austria (6)
Belgium (17)
British Virgin Islands (1)
Cameroon (2)
Canada (3)
Chile (1)
China (1)
Croatia (2)
Cyprus (1)
Czech Republic (5)
Denmark (9)
Estonia (1)
Finland (5)
France (39)
Germany (53)
Greece (8)
Hungary (3)
India (2)
Ireland (4)
Israel (7)
Italy (30)
Japan (1)
Lithuania (1)
Malta (1)
Netherlands (27)
Norway (5)
Poland (4)
Portugal (1)
Romania (2)
Slovenia (1)
South Africa (2)
Spain (17)
Sweden (25)
Switzerland (20)
Tanzania (1)
Thailand (1)
Turkey (2)
Uganda (1)
United Kingdom (48)
United States (5)
Vietnam (1)
Zambia (1)


English (56)

Advanced search

Results 1 - 10 of 56
Order by: Results/page:
12 3 4 5 6 > 
European Consortium for Communicating Stem Cell Research
ID: 241878
Start date: 2010-03-01, End date: 2015-02-28
The European Consortium for Communicating Stem Cell Research, EUROSTEMCELL, brings together the major current FP6 and FP7 stem cell projects, the European Clinical Research Infrastructure Network, and four internationally recognized European stem cell centres to develop a com...
Programme: FP7-HEALTH
Record Number: 94445
Last updated on: 2018-01-03
European stem cell consortium for neural cell replacement, reprogramming and functional brain repair
ID: 602278
Start date: 2013-10-01, End date: 2017-09-30
Neurostemcellrepair aims at taking human stem cells through the final steps toward clinical application in cell replacement therapy for neurological disorders. PD will be taken as the prototypical disease because stem cell therapy is now close to clinical translation. Moreove...
Programme: FP7-HEALTH
Record Number: 110638
Last updated on: 2017-09-24
ID: 266777
Start date: 2011-01-01, End date: 2015-12-31
The goal of HeMiBio is to develop a hepatic microfluidic bioreactor from human iPSC-derived hepatocytes, hepatic sinusoidal endothelial cells (HSEC) and stellate cells (HSC), suitable for inclusion in a repeated dose toxicity testing strategy of pharmaceuticals/cosmetic ingre...
Programme: FP7-HEALTH
Record Number: 105662
Last updated on: 2017-06-12
Characterization and quantitative modeling of DNA mismatch repair and its role in the maintenance of genomic stability and cancer avoidance
ID: 223545
Start date: 2008-11-01, End date: 2012-10-31
Mismatch2model: Characterization and quantitative modeling of DNA mismatch repair and its role in the maintenance of genomic stability and cancer avoidance DNA mismatch repair (MMR) plays a crucial role in the maintenance of genomic stability. In both bacteria and eukaryotes,...
Programme: FP7-HEALTH
Record Number: 88358
Last updated on: 2017-05-30
Mathematical modelling of beta-catenin and ras signalling in liver and its impact on proliferation, tissue organization and formation of hepatocellular carcinomas
ID: 223188
Start date: 2008-11-01, End date: 2011-10-31
The goal of the CANCERSYS project is to establish a multi-scale model for two major signalling pathways involved in the formation of hepatocellular carcinoma, the beta-catenin and ras signalling pathways. Integrative studies linking measurements in primary heptocytes with eff...
Programme: FP7-HEALTH
Record Number: 88500
Last updated on: 2017-05-30
Genomic determinants of inflammation: from physical measurements to system perturbation and mathematical modeling
ID: 222008
Start date: 2008-12-01, End date: 2012-05-31
Inflammation is a complex biochemical and cellular response essential for the viability of higher organisms because of its requirement in anti-microbial defence and protection from the consequences of tissue injury. However, uncontrolled or sustained inflammation leads to sev...
Programme: FP7-HEALTH
Record Number: 88915
Last updated on: 2017-05-30
Search for new therapeutic agents against complicated obesity by reprofiling existing drugs
ID: 223713
Start date: 2008-12-01, End date: 2012-05-31
Obesity is one of the most serious and fast-growing health problem in the European Union, and a leading cause of diabetes. The main barrier for approval of an anti-obesity drug is the safety requirements. We propose to overcome this barrier by discovering phenotypes and bioma...
Programme: FP7-HEALTH
Record Number: 88879
Last updated on: 2017-05-29
A systems approach linking genotype and environment to phenotype: oxidative stress response mechanisms in fission yeast
ID: 223539
Start date: 2008-10-01, End date: 2012-03-31
Cellular protection against oxidative damage is relevant to ageing and numerous complex diseases. We plan to use fission yeast as a model organism to gain a systems-level understanding of the oxidative stress response and obtain insights into the interplay of variable genotyp...
Programme: FP7-HEALTH
Record Number: 88522
Last updated on: 2017-05-29
Ascertaining Barriers for Compliance: policies for safe, effective and cost-effective use of medicines in Europe
ID: 223477
Start date: 2009-01-01, End date: 2012-06-30
Medication non-compliance is highly prevalent across all medical conditions, and represents a major barrier for realising the benefits of evidence-based therapies. The aim of the project is to produce evidence-based policy recommendations for improving patient compliance and ...
Programme: FP7-HEALTH
Record Number: 88878
Last updated on: 2017-05-29
Systems biology of phagosome formation and maturation, modulation by intracellular pathogens
ID: 223451
Start date: 2008-11-01, End date: 2012-04-30
To address the question of how intracellular pathogens modulate phagosome trafficking in the host cell we propose to use a systems biology approach, using an iterative cycle of experimental data, model, new experimental data, improved model. The ultimate aim of our project is...
Programme: FP7-HEALTH
Record Number: 88488
Last updated on: 2017-05-29
12 3 4 5 6 > 
List retrieved on: 2018-10-19
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top